Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 744 All time
- Disclosed funding
- $25.4B 609 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| ET Elysium TherapeuticsCompany profile Develops treatments to prevent and reverse overdoses caused by synthetic opioids Develops treatments to prevent and reverse overdoses caused by synthetic opioids | $7.5M | SAFEUndisclosed | Healthtech, Biotech | United States | Investors Undisclosed | |
| NS Nami SurgicalCompany profile Develops high-performance miniaturised ultrasonic scalpels for robotic-assisted surgery Develops high-performance miniaturised ultrasonic scalpels for robotic-assisted surgery | £1.9M | Undisclosed | Healthtech | United Kingdom | Investors | |
| CT CraniUS TherapeuticsCompany profile Develops implantable platform to bypass blood-brain barrier for drug delivery Develops implantable platform to bypass blood-brain barrier for drug delivery | $20M | Series B | Healthtech | United States | Investors Undisclosed | |
| O OriginCompany profile Provides pelvic floor physical therapy and whole-body musculoskeletal care for women Provides pelvic floor physical therapy and whole-body musculoskeletal care for women | Undisclosed | Series B | Healthtech | United States | Investors | |
| E EvaroCompany profile Provides embeddable prescribing and pharmacy infrastructure for consumer brands. Provides embeddable prescribing and pharmacy infrastructure for consumer brands. | $25M | Series A | Healthtech | United Kingdom | Investors | |
| N NavidenceCompany profile Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research | Undisclosed | Seed | Healthtech | United States | Investors | |
| SM Develops real-time microscopy for surgical procedures | €20M | Undisclosed | Healthtech | Belgium | Investors | |
| GK Provides data analysis for quality and regulatory intelligence. | Undisclosed | Pre-SeedPre-seed | Healthtech, Biotech | United States | Investors | |
| M Enables fitness creators to train their communities at scale | €2M | Undisclosed | Healthtech, Consumer | United Kingdom | Investors | |
| 4 4DMedicalCompany profile Software that extracts functional lung information from routine chest imaging for clinical assessment. Software that extracts functional lung information from routine chest imaging for clinical assessment. | >$100M | Undisclosed | Healthtech | Australia | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →